Showing results (1451-1460 of 1,523) with videos related to
Sort By:
Pageof 153
JAMA Network Open|April 12, 2024
Remote Monitoring and Data Collection for Decentralized Clinical TrialsBobby Daly, Otis W Brawley, Mary K Gospodarowicz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 16, 2021
Timing and Origins of Local and Distant Metastases in Lung CancerWen-Fang Tang, Min Wu, Hua Bao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2017
Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung CancerAnna Li, Jin-Ji Yang, Xu-Chao Zhang, et al.Journal of Hematology & Oncology|April 17, 2020
Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter studyChang Lu, Xiao-Rong Dong, Jun Zhao, et al.The Lancet. Respiratory Medicine|July 26, 2024
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 studyJin-Ji Yang, Jianying Zhou, Si-Yang Maggie Liu, et al.Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancerHai-Yan Tu, E-E Ke, Jin-Ji Yang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2016
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLCChristian Manegold, Anne-Marie C Dingemans, Jhanelle E Gray, et al.The Lancet. Oncology|August 17, 2013
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trialYuankai Shi, Li Zhang, Xiaoqing Liu, et al.The Lancet. Oncology|January 16, 2015
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trialsJames Chih-Hsin Yang, Yi-Long Wu, Martin Schuler, et al.Pageof 153